Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572284 · ClinicalTrials.gov registry record · Phase 1
Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer
A Phase 1 study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT02572284 is a Phase 1 study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 7 participants.
The verdict
NCT02572284, a Phase 1 study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects, good and/or bad, of different doses of SBRT given before prostatectomy. Depending when participants enter the study, they will be treated with either 5 or 6 gray (Gy) per day of radiation. A Gy is a measure of radiation dose. The standard dose is 10Gy per day when SBRT is the only treatment to the prostate and no surgery is planned. The researchers want to see which dose of radiation will work best with the least amount of side effects. About 4-6 weeks after SBRT, participants will have a prostatectomy.
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- OTHER Quality of Life Questionnaires
- PROCEDURE Prostatectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2016-01-27 |
| Est. Completion | 2019-10-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02572284
The ClinicalTrials.gov registry entry for NCT02572284 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT02572284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02572284 about?
NCT02572284 is a clinical study titled "Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer". The purpose of this study is to compare the effects, good and/or bad, of different doses of SBRT given before prostatectomy. Depending when participants enter the study, they will be treated with either 5 or 6 gray (Gy) per day of radiation. A Gy is a measure of radiation dose. The standard dose is ...
What is the current status of trial NCT02572284?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2016-01-27. Estimated completion is 2019-10-23.
What interventions are being tested in trial NCT02572284?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Quality of Life Questionnaires (OTHER), Prostatectomy (PROCEDURE).
Who is sponsoring clinical trial NCT02572284?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.